- Institut de Recerca Biomèdica de Lleida (IRB-Lleida)
Institut d'investigació
![Foto de - Institut de Recerca Biomèdica de Lleida (IRB-Lleida)](/img/noimage.png)
![Foto de Universidad de Castilla-La Mancha](/img/noimage_org.png)
Universidad de Castilla-La Mancha
Ciudad Real, EspañaPublications en collaboration avec des chercheurs de Universidad de Castilla-La Mancha (17)
2024
-
Effect of CPAP Treatment on Cardiovascular Outcomes
Archivos de Bronconeumologia
2022
-
A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System
International Journal of COPD, Vol. 17, pp. 1431-1442
2021
-
Economic evaluation of a multimodal intervention in pre-frail and frail older people with diabetes mellitus: the MID-FRAIL project
Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 21, Núm. 1, pp. 111-118
-
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1
Autophagy, Vol. 17, Núm. 1, pp. 1-382
2020
-
Economic Evaluation for Pricing and Reimbursement of New Drugs in Spain: Fable or Desideratum?
Value in Health, Vol. 23, Núm. 1, pp. 25-31
2019
-
Gender Differences in Labour Losses Associated with Smoking-Related Mortality
International journal of environmental research and public health, Vol. 16, Núm. 19
-
Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?
Health Policy, Vol. 123, Núm. 2, pp. 152-158
-
What attributes should be included in a discrete choice experiment related to health technologies? A systematic literature review
PLoS ONE, Vol. 14, Núm. 7
2018
-
Determining the Value of Two Biologic Drugs for Chronic Inflammatory Skin Diseases: Results of a Multi-Criteria Decision Analysis
BioDrugs, Vol. 32, Núm. 3, pp. 281-291
-
Economic impact of HIV in the highly active antiretroviral therapy Era - Reflections looking forward
AIDS Reviews, Vol. 20, Núm. 4, pp. 226-235
2017
-
Increasing cervical cancer screening coverage: A randomised, community-based clinical trial
PLoS ONE, Vol. 12, Núm. 1
-
The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review
PharmacoEconomics, Vol. 35, Núm. 3, pp. 331-345
2015
-
Cuestiones controvertidas en evaluación económica (II): Medidas de resultado en salud de las intervenciones sanitarias
Revista Espanola de Salud Publica, Vol. 89, Núm. 2, pp. 125-135
-
Especialcuestiones controvertidas en evaluación económica (III): intervenciones sanitarias en tres situaciones especiales: enfermedades raras, tratamientos al final de la viday externalidades en las evaluaciones
Revista Espanola de Salud Publica, Vol. 89, Núm. 3, pp. 237-247
2014
-
Economic impact of HIV/AIDS: a systematic review in five European countries
Health Economics Review, Vol. 4, Núm. 1
2008
-
BAX and BAK proteins are required for cyclin-dependent kinase inhibitory drugs to cause apoptosis
Molecular Cancer Therapeutics, Vol. 7, Núm. 12, pp. 3800-3806
2006
-
Pyruvate protects cerebellar granular cells from 6-hydroxydopamine-induced cytotoxicity by activating the Akt signaling pathway and increasing glutathione peroxidase expression
Neurobiology of Disease, Vol. 24, Núm. 2, pp. 296-307